Literature DB >> 21755926

Relative quantification: characterization of bias, variability and fold changes in mass spectrometry data from iTRAQ-labeled peptides.

Douglas W Mahoney1, Terry M Therneau, Carrie J Heppelmann, Leeann Higgins, Linda M Benson, Roman M Zenka, Pratik Jagtap, Gary L Nelsestuen, H Robert Bergen, Ann L Oberg.   

Abstract

Shotgun proteomics via mass spectrometry (MS) is a powerful technology for biomarker discovery that has the potential to lead to noninvasive disease screening mechanisms. Successful application of MS-based proteomics technologies for biomarker discovery requires accurate expectations of bias, reproducibility, variance, and the true detectable differences in platforms chosen for analyses. Characterization of the variability inherent in MS assays is vital and should affect interpretation of measurements of observed differences in biological samples. Here we describe observed biases, variance structure, and the ability to detect known differences in spike-in data sets for which true relative abundance among defined samples were known and were subsequently measured with the iTRAQ technology on two MS platforms. Global biases were observed within these data sets. Measured variability was a function of mean abundance. Fold changes were biased toward the null and variance of a fold change was a function of protein mass and abundance. The information presented herein will be valuable for experimental design and analysis of the resulting data.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21755926      PMCID: PMC3166364          DOI: 10.1021/pr2001308

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  34 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

3.  Faster cyclic loess: normalizing RNA arrays via linear models.

Authors:  Karla V Ballman; Diane E Grill; Ann L Oberg; Terry M Therneau
Journal:  Bioinformatics       Date:  2004-05-27       Impact factor: 6.937

4.  Addressing accuracy and precision issues in iTRAQ quantitation.

Authors:  Natasha A Karp; Wolfgang Huber; Pawel G Sadowski; Philip D Charles; Svenja V Hester; Kathryn S Lilley
Journal:  Mol Cell Proteomics       Date:  2010-04-10       Impact factor: 5.911

5.  Joint estimation of calibration and expression for high-density oligonucleotide arrays.

Authors:  Ann L Oberg; Douglas W Mahoney; Karla V Ballman; Terry M Therneau
Journal:  Bioinformatics       Date:  2006-07-28       Impact factor: 6.937

6.  Assessing bias in experiment design for large scale mass spectrometry-based quantitative proteomics.

Authors:  Amol Prakash; Brian Piening; Jeff Whiteaker; Heidi Zhang; Scott A Shaffer; Daniel Martin; Laura Hohmann; Kelly Cooke; James M Olson; Stacey Hansen; Mark R Flory; Hookeun Lee; Julian Watts; David R Goodlett; Ruedi Aebersold; Amanda Paulovich; Benno Schwikowski
Journal:  Mol Cell Proteomics       Date:  2007-07-07       Impact factor: 5.911

7.  Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA.

Authors:  Ann L Oberg; Douglas W Mahoney; Jeanette E Eckel-Passow; Christopher J Malone; Russell D Wolfinger; Elizabeth G Hill; Leslie T Cooper; Oyere K Onuma; Craig Spiro; Terry M Therneau; H Robert Bergen
Journal:  J Proteome Res       Date:  2008-01-04       Impact factor: 4.466

8.  A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemia.

Authors:  Yi Zhang; Manor Askenazi; Jingrui Jiang; C John Luckey; James D Griffin; Jarrod A Marto
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

9.  Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases.

Authors:  Andrew Pierce; Richard D Unwin; Caroline A Evans; Stephen Griffiths; Louise Carney; Liqun Zhang; Ewa Jaworska; Chia-Fang Lee; David Blinco; Michal J Okoniewski; Crispin J Miller; Danny A Bitton; Elaine Spooncer; Anthony D Whetton
Journal:  Mol Cell Proteomics       Date:  2007-10-21       Impact factor: 5.911

10.  Evaluation of a new high-dimensional miRNA profiling platform.

Authors:  Julie M Cunningham; Ann L Oberg; Pedro M Borralho; Betsy T Kren; Amy J French; Liang Wang; Brian M Bot; Bruce W Morlan; Kevin A T Silverstein; Rod Staggs; Yan Zeng; Anne-Francoise Lamblin; Christopher A Hilker; Jian-Bing Fan; Clifford J Steer; Stephen N Thibodeau
Journal:  BMC Med Genomics       Date:  2009-08-27       Impact factor: 3.063

View more
  23 in total

1.  Isobaric labeling and data normalization without requiring protein quantitation.

Authors:  Phillip D Kim; Bhavinkumar B Patel; Anthony T Yeung
Journal:  J Biomol Tech       Date:  2012-04

2.  Proteomic analysis of early-stage embryos: implications for egg quality in hapuku (Polyprion oxygeneios).

Authors:  Yair Y Kohn; Jane E Symonds; Torsten Kleffmann; Shinichi Nakagawa; Malgorzata Lagisz; P Mark Lokman
Journal:  Fish Physiol Biochem       Date:  2015-07-18       Impact factor: 2.794

3.  Defining, comparing, and improving iTRAQ quantification in mass spectrometry proteomics data.

Authors:  Lina Hultin-Rosenberg; Jenny Forshed; Rui M M Branca; Janne Lehtiö; Henrik J Johansson
Journal:  Mol Cell Proteomics       Date:  2013-03-07       Impact factor: 5.911

4.  Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.

Authors:  Jian-Ying Zhou; Lijun Chen; Bai Zhang; Yuan Tian; Tao Liu; Stefani N Thomas; Li Chen; Michael Schnaubelt; Emily Boja; Tara Hiltke; Christopher R Kinsinger; Henry Rodriguez; Sherri R Davies; Shunqiang Li; Jacqueline E Snider; Petra Erdmann-Gilmore; David L Tabb; R Reid Townsend; Matthew J Ellis; Karin D Rodland; Richard D Smith; Steven A Carr; Zhen Zhang; Daniel W Chan; Hui Zhang
Journal:  J Proteome Res       Date:  2017-11-16       Impact factor: 4.466

Review 5.  Quality assessment for clinical proteomics.

Authors:  David L Tabb
Journal:  Clin Biochem       Date:  2012-12-12       Impact factor: 3.281

6.  An Efficient Approach to Evaluate Reporter Ion Behavior from MALDI-MS/MS Data for Quantification Studies Using Isobaric Tags.

Authors:  Stephanie M Cologna; Christopher A Crutchfield; Brian C Searle; Paul S Blank; Cynthia L Toth; Alexa M Ely; Jaqueline A Picache; Peter S Backlund; Christopher A Wassif; Forbes D Porter; Alfred L Yergey
Journal:  J Proteome Res       Date:  2015-09-03       Impact factor: 4.466

7.  Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry.

Authors:  Adriana Bora; Ceereena Ubaida Mohien; Raghothama Chaerkady; Linda Chang; Richard Moxley; Ned Sacktor; Norman Haughey; Justin C McArthur; Robert Cotter; Avindra Nath; David R Graham
Journal:  J Neurovirol       Date:  2014-07-24       Impact factor: 2.643

8.  The N-DRC forms a conserved biochemical complex that maintains outer doublet alignment and limits microtubule sliding in motile axonemes.

Authors:  Raqual Bower; Douglas Tritschler; Kristyn Vanderwaal; Catherine A Perrone; Joshua Mueller; Laura Fox; Winfield S Sale; M E Porter
Journal:  Mol Biol Cell       Date:  2013-02-20       Impact factor: 4.138

Review 9.  Statistical methods for quantitative mass spectrometry proteomic experiments with labeling.

Authors:  Ann L Oberg; Douglas W Mahoney
Journal:  BMC Bioinformatics       Date:  2012-11-05       Impact factor: 3.169

10.  Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow.

Authors:  Zhiyun Cao; Sachin Yende; John A Kellum; Renã A S Robinson
Journal:  Int J Proteomics       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.